A Trial of Famitinib in Patients With Failure of First-Line Treatment For Intrahepatic Cholangiocarcinoma
Clinical trial NCT04479904 · WITHDRAWN
Trial details
- NCT number
- NCT04479904
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-10
- Primary completion
- 2021-12-10
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.